Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 44, 2010 - Issue 1
Submit an article Journal homepage
112
Views
12
CrossRef citations to date
0
Altmetric
Urology

Long-term treatment and prognostic factors of α1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot study comparing naftopidil and tamsulosin hydrochloride

Yoshio Kawachi Department of Urology, Juntendo University Urayasu Hospital, Urayasu City, Japan Urayasu City, JapanCorrespondence[email protected]
,
Toru Sakurai Department of Urology, Juntendo University Urayasu Hospital, Urayasu City, Japan Urayasu City, Japan
,
Sosuke Sugimura Department of Urology, Juntendo University Urayasu Hospital, Urayasu City, Japan Urayasu City, Japan
,
Shinji Iwata Department of Urology, Juntendo University Urayasu Hospital, Urayasu City, Japan Urayasu City, Japan
,
Kensho Noto Department of Urology, Juntendo University Urayasu Hospital, Urayasu City, Japan Urayasu City, Japan
,
Shin-Ichi Honda Department of Urology, Juntendo University Urayasu Hospital, Urayasu City, Japan Urayasu City, Japan
&
Osamu Maruyama Department of Urology, Kamata Social Insurance Hospital, Urayasu City, Japan
 show all
Pages 38-45 | Received 09 Jun 2008, Accepted 03 Sep 2009, Published online: 22 Jan 2010

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Naoya Masumori, Taiji Tsukamoto, Akihiko Shibuya, Noriomi Miyao, Yasuharu Kunishima & Akihiko Iwasawa. (2016) Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan. Patient Preference and Adherence 10, pages 1309-1316.
Read now
Fabio Castiglione, Fabio Benigni, Alberto Briganti, Andrea Salonia, Luca Villa, Alessandro Nini, Ettore Di Trapani, Umberto Capitanio, Petter Hedlund & Francesco Montorsi. (2014) Naftopidil for the treatment of benign prostate hyperplasia: a systematic review. Current Medical Research and Opinion 30:4, pages 719-732.
Read now
Naoya Masumori. (2011) Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia. Therapeutics and Clinical Risk Management 7, pages 227-238.
Read now

Articles from other publishers (9)

Daichi Kikuchi, Yoichiro Kato, Misato Takayama, Seiko Kanzaki, Akito Ito, Daiki Ikarashi, Shigekatsu Maekawa, Renpei Kato, Takashi Seo, Yukihisa Owari, Tatsuru Nozawa, Kazumasa Isurugi, Hiromitsu Fujisawa, Takashi Ujiie, Mitsugu Kanehira, Ryo Takata & Wataru Obara. (2020) A prospective study on the association between post-voiding residual volume and quality of life during bacille Calmette-Guérin (BCG) instillation therapy for non–muscle-invasive bladder cancer. Journal of Clinical Urology 14:4, pages 255-261.
Crossref
Se Yun Kwon, Kyung Seop Lee, Tag Keun Yoo, Jae Il Chung, Ji Youl Lee, Jun Hyuk Hong, Seong Il Seo, Tae Young Jung, Cheol Kwak, Taek Won Kang & Seok-Joong Yun. (2018) Comparison of the Effect of Naftopidil 75 mg and Tamsulosin 0.2 mg on the Bladder Storage Symptom With Benign Prostatic Hyperplasia: Prospective, Multi-institutional Study. Urology 111, pages 145-150.
Crossref
Nathaly François, Raunak D. Patel & Kevin T. McVary. 2014. Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia 70 89 .
Satoshi Yamaguchi, Hiroaki Osanai, Atsushi Numata, Masaki Watanabe & Hidehiro Kakizaki. (2013) α1D/A-adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: Efficacy of dose increase therapy. International Journal of Urology 20:5, pages 513-519.
Crossref
Noboru Hara, Takaki Mizusawa, Kenji Obara & Kota Takahashi. (2012) The role of naftopidil in the management of benign prostatic hyperplasia. Therapeutic Advances in Urology 5:2, pages 111-119.
Crossref
Naoya Masumori, Taiji Tsukamoto, Hiroki Horita, Ken-ichi Sunaoshi, Yoshinori Tanaka, Koh Takeyama, Eiji Sato & Noriomi Miyao. (2013) α1-blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study. International Journal of Urology 20:4, pages 421-428.
Crossref
Yukio Homma, Momokazu Gotoh, Osamu Yokoyama, Naoya Masumori, Akihiro Kawauchi, Tomonori Yamanishi, Osamu Ishizuka, Narihito Seki, Toshiyuki Kamoto, Atsushi Nagai & Seiichiro Ozono. (2011) JUA clinical guidelines for benign prostatic hyperplasia. International Journal of Urology 18:11, pages e1-e33.
Crossref
Yukio Homma, Momokazu Gotoh, Osamu Yokoyama, Naoya Masumori, Akihiro Kawauchi, Tomonori Yamanishi, Osamu Ishizuka, Narihito Seki, Toshiyuki Kamoto, Atsushi Nagai & Seiichiro Ozono. (2011) Outline of JUA clinical guidelines for benign prostatic hyperplasia. International Journal of Urology 18:11, pages 741-756.
Crossref
Robert F Donnell. (2011) Benign prostate hyperplasia: a review of the year's progress from bench to clinic. Current Opinion in Urology 21:1, pages 22-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.